A reasonable chance it could cause serious harm or death.
Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.
| Brand name | CETIRIZINE HYDROCHLORIDE |
| Generic name | CETIRIZINE HYDROCHLORIDE |
| Active ingredient(s) | CETIRIZINE HYDROCHLORIDE |
| Distributed by / for | Rising Pharma Holdings, Inc., East Brunswick, NJ 08816 |
| NDC | 16571-401-10 |
| Full product label | Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-401-10. |
| Recalling firm | JB Chemicals and Pharmaceuticals Ltd |
| Distribution | Nationwide in the USA |
| Quantity | 34,020 100-count bottles. |
| Recall initiated | 2026-06-24 |
| Report date | 2026-07-29 |
| Recall completed | — |
| Recall number | D-0732-2026 |
| Classification | Class I |
| FDA status | Ongoing |
| Origin on file | Mumbai N/A India |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗